The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications. (Q38542016)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

review article

1 reference

title

The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Ruggero De Maria

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Laura Pizzuti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Marcella Mottolese

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Monica Bartucci

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Marcello Maugeri-Saccà

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Luigi Di Lauro

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

2 July 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

Expert Reviews in Molecular Medicine

18 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

e14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase.

18 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

The biology of YAP/TAZ: hippo signaling and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Elucidation of a universal size-control mechanism in Drosophila and mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

The Hippo pathway and human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Acidic stress promotes a glioma stem cell phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Modulating F-actin organization induces organ growth by affecting the Hippo pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Genetic variegation of clonal architecture and propagating cells in leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Actin-Capping Protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

YAP1 increases organ size and expands undifferentiated progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Clonal evolution in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Identification of pancreatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Tumorigenic and metastatic activity of human thyroid cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Identification and expansion of the tumorigenic lung cancer stem cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Physical interaction with Yes-associated protein enhances p73 transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Yes-associated protein (YAP) functions as a tumor suppressor in breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

KRAS and YAP1 converge to regulate EMT and tumor survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

'Cancer associated fibroblasts'--more than meets the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

A temporal requirement for Hippo signaling in mammary gland differentiation, growth, and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Yes-associated protein promotes tumour development in luminal epithelial derived breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

The transcriptional regulators TAZ and YAP direct transforming growth factor β-induced tumorigenic phenotypes in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

The ciliopathy disease protein NPHP9 promotes nuclear delivery and activation of the oncogenic transcriptional regulator TAZ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

NPHP4, a cilia-associated protein, negatively regulates the Hippo pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

TEADs mediate nuclear retention of TAZ to promote oncogenic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

The Hippo transducer TAZ interacts with the SWI/SNF complex to regulate breast epithelial lineage commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Bone metastatic process of breast cancer involves methylation state affecting E-cadherin expression through TAZ and WWOX nuclear effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Gene expression profiling in breast cancer: classification, prognostication, and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

DNA damage repair pathways in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Cancer Stem Cells and Chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Metabolic control of YAP and TAZ by the mevalonate pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Molecular profiling and computational network analysis of TAZ-mediated mammary tumorigenesis identifies actionable therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

A laminin 511 matrix is regulated by TAZ and functions as the ligand for the α6Bβ1 integrin to sustain breast cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Characterization of TAZ domains important for the induction of breast cancer stem cell properties and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Role of YAP/TAZ in mechanotransduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Yes-Associated Protein (YAP) is a critical mediator of c-Jun-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

7 January 2021

The Hippo signaling pathway in stem cell biology and cancer

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

7 January 2021

MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

7 January 2021

The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

7 January 2021

Distinct types of tumor-initiating cells form human colon cancer tumors and metastases

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

7 January 2021

Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

7 January 2021

Hypoxia inducible factor-1 is activated by transcriptional co-activator with PDZ-binding motif (TAZ) versus WWdomain-containing oxidoreductase (WWOX) in hypoxic microenvironment of bone metastasis from breast cancer

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

7 January 2021

Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional TargetsCyr61andCTGF

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

7 January 2021

Metaplastic carcinoma show different expression pattern of YAP compared to triple-negative breast cancer.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

7 January 2021

A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

7 January 2021

Therapeutic targeting of cancer stem cells

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

7 January 2021

Identifiers

DOI

10.1017/ERM.2015.12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json